Literature DB >> 25193965

Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.

Cristina Gattazzo1, Antonella Teramo2, Francesca Passeri1, Elena De March3, Samuela Carraro3, Valentina Trimarco1, Federica Frezzato1, Tamara Berno3, Gregorio Barilà3, Veronica Martini1, Francesco Piazza1, Livio Trentin1, Monica Facco1, Gianpietro Semenzato4, Renato Zambello1.   

Abstract

The etiology of chronic large granular lymphocyte proliferations is largely unknown. Although these disorders are characterized by the expansion of different cell types (T and natural killer) with specific genetic features and abnormalities, several lines of evidence suggest a common pathogenetic mechanism. According to this interpretation, we speculated that in patients with natural killer-type chronic lymphoproliferative disorder, together with natural killer cells, also T lymphocytes undergo a persistent antigenic pressure, possibly resulting in an ultimate clonal T-cell selection. To strengthen this hypothesis, we evaluated whether clonal T-cell populations were detectable in 48 patients with killer immunoglobulin-like receptor-restricted natural killer-type chronic lymphoproliferative disorder. At diagnosis, in half of the patients studied, we found a clearly defined clonal T-cell population, despite the fact that all cases presented with a well-characterized natural killer disorder. Follow-up analysis confirmed that the TCR gamma rearrangements were stable over the time period evaluated; furthermore, in 7 patients we demonstrated the appearance of a clonal T subset that progressively matures, leading to a switch between killer immunoglobulin-like receptor-restricted natural killer-type disorder to a monoclonal T-cell large granular lymphocytic leukemia. Our results support the hypothesis that a common mechanism is involved in the pathogenesis of these disorders. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25193965      PMCID: PMC4258759          DOI: 10.3324/haematol.2014.105726

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  42 in total

1.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

2.  Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study.

Authors:  F Pandolfi; T P Loughran; G Starkebaum; T Chisesi; T Barbui; W C Chan; J C Brouet; G De Rossi; R W McKenna; F Salsano
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

3.  How I treat LGL leukemia.

Authors:  Thierry Lamy; Thomas P Loughran
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

4.  Large Granular Lymphocyte Leukemia.

Authors: 
Journal:  Cancer Control       Date:  1998-01       Impact factor: 3.302

Review 5.  State of the art in natural killer cell malignancies.

Authors:  G Semenzato; F Marino; R Zambello
Journal:  Int J Lab Hematol       Date:  2011-09-06       Impact factor: 2.877

6.  Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium.

Authors:  W V Williams; Q Fang; D Demarco; J VonFeldt; R B Zurier; D B Weiner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

7.  Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes.

Authors:  Pearlie Kay Epling-Burnette; Jeffrey S Painter; Pratima Chaurasia; Fanqi Bai; Sheng Wei; Julie Y Djeu; Thomas P Loughran
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

Review 8.  The role of CD95 in the regulation of peripheral T-cell apoptosis.

Authors:  Andreas Krueger; Stefanie C Fas; Sven Baumann; Peter H Krammer
Journal:  Immunol Rev       Date:  2003-06       Impact factor: 12.988

9.  Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.

Authors:  A Moretta; S Sivori; M Vitale; D Pende; L Morelli; R Augugliaro; C Bottino; L Moretta
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  T-cell receptor gene expression in tumour-infiltrating lymphocytes and peripheral blood lymphocytes of patients with nasopharyngeal carcinoma.

Authors:  Y Chen; C T Chew; S H Chan
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  6 in total

1.  Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia.

Authors:  Elizabeth A Morgan; Mark N Lee; Daniel J DeAngelo; David P Steensma; Richard M Stone; Frank C Kuo; Jon C Aster; Christopher J Gibson; R Coleman Lindsley
Journal:  Blood Adv       Date:  2017-09-13

Review 2.  All that glitters is not LGL Leukemia.

Authors:  Gianpietro Semenzato; Antonella Teramo; Giulia Calabretto; Vanessa Rebecca Gasparini; Renato Zambello
Journal:  Leukemia       Date:  2022-09-15       Impact factor: 12.883

Review 3.  Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.

Authors:  Kazuo Oshimi
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

4.  Indolent T-cell lymphoproliferative disease with synchronous diffuse large B-cell lymphoma: A case report.

Authors:  Linjie Guo; Zhonghui Wen; Xueying Su; Shuyuan Xiao; Yufang Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia.

Authors:  Barbara Mariotti; Giulia Calabretto; Marzia Rossato; Antonella Teramo; Monica Castellucci; Gregorio Barilà; Matteo Leoncin; Cristina Vicenzetto; Monica Facco; Gianpietro Semenzato; Flavia Bazzoni; Renato Zambello
Journal:  Haematologica       Date:  2019-08-29       Impact factor: 9.941

6.  Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging Presentations.

Authors:  Natali Pflug; Annika Littauer; David Beverungen; Aleksandra Sretenovic; Linus Wahnschaffe; Till Braun; Annika Dechow; Dennis Jungherz; Moritz Otte; Astrid Monecke; Enrica Bach; Georg-Nikolaus Franke; Sebastian Schwind; Madlen Jentzsch; Uwe Platzbecker; Marco Herling; Vladan Vucinic
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.